From contributing to an interactive activities map to taking up challenges and advocating for local proclamations, supporters are set to mark Myasthenia Gravis Awareness Month, held each June. The aim is to raise global awareness among the general public, as well as among policymakers, public authorities, industry representatives, scientists, and…
News
Thymectomy – surgical removal of the thymus gland — may be a better option for treating patients with early-onset non-thymomatous myasthenia gravis (MG), a study has found. According to study data, the surgical procedure did not confer an added benefit over non-invasive treatment options for patients with late-onset disease.
A micro RNA molecule called miR-146a was found at high levels in the blood of patients with myasthenia gravis (MG), and this is thought to contribute to disease development, a single-site study suggests. The findings put forward miR-146a as “a suitable candidate marker for diagnosing MG,” the researchers wrote.
The rare case of a female patient who developed myasthenia gravis (MG) in association with Hodgkin’s lymphoma, a type of blood cancer, highlighted the link between these conditions and the therapeutic challenge they pose. Her case was described…
Patients with myasthenia gravis (MG) and self-reactive antibodies against the muscle-specific kinase (MuSK) protein are more likely to have poorer outcomes when experiencing a myasthenic crisis than other MG patients, a study suggests. Outcomes linked to MuSK antibody production include longer periods of hospitalization or admittance to intensive care,…
A new type of plasma exchange treatment, called double-filtration plasmapheresis (DFPP), may be effective and safe for short-term relief of myasthenia gravis (MG) symptoms, a review study has found. These findings may have important clinical implications, especially for patients with severe or critical MG, the researchers noted. The review,…
People with myasthenia gravis (MG) who have difficulty swallowing are more likely to have poor clinical outcomes, according to a recent study. Data from the study also indicates that low levels of albumin — a protein found in the blood that helps transporting hormones and other key molecules in…
Three patients with myasthenia gravis (MG) were safely treated for COVID-19 with a combination of the antiviral medication Veklury (remdesivir) and the anti-inflammatory dexamethasone, while having no apparent worsening of their MG symptoms. Veklury…
Thymectomy, or surgical removal of the thymus, can lower medication use and lessen disease severity in people with myasthenia gravis (MG), regardless of age, sex, or medical history, an observational study has found. Data from the study also indicated that younger female patients with early onset MG, an…
Editor’s note: The Myasthenia Gravis News team is providing in-depth coverage of the 2021 Virtual AAN Annual Meeting, April 17–22. Go here to read the latest stories from the conference. Many people with myasthenia gravis (MG) experience unusual fatigue, including those with pure ocular disease or with…
Recent Posts
- Zilbrysq autoinjector found safe, effective in trials for use in gMG
- Dieting to be in better shape, not to have a perfect shape
- Mental health challenges are often an invisible aspect of MG
- New drug cemdisiran may offer gMG symptom relief with 4 doses a year
- Cell therapy KYV-101 eases symptoms in small trial for hard-to-treat gMG